The new, modern design includes a range of exciting new features that enhance the user experience for candidates and clients:
ICON today announced the second in its four-part Solution Provider educational webinar series in collaboration with DIA
ICON today reported its financial results for the first quarter ended March 31, 2013. For the first quarter, net revenues grew 26% year on year to $316.8 million from $252.3 million in Q1 2012.
ICON today announced that is has received the 2013 “Partnership Pioneers of the Year” award in recognition of its strategic partnership with Pfizer and PAREXEL
ICON, in conjunction with University College Dublin (UCD), today announced the launch of the ICON Business Academy
New thought leadership program offers expert insight into value-driven strategies for clinical development.
ICON today announced the appointment of Professor William Hall as a non-executive director
ICON to share industry insights on oncology, technology, biomarkers and late phase development
ICON today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services Division of Cross Country Healthcare, Inc. (NASDAQ:CCRN), for a cash consideration of $52 million, plus an earn-out of up to $3.75 million related to certain performance-based milestones